Real‑world and prospective data demonstrate the role of clearance‑informed, precision‑guided dosing in supporting ...
Wearable sensors that use microneedles to painlessly take samples at skin level could help personalize health care and enable ...
BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics (VERV), a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced the clearance of ...
Teens suffering from anxiety, panic attacks and trauma have a new, drug-free option for addressing their mental health. The Seattle-area company Freespira announced that it received U.S. Food and Drug ...
ORKA-001 also met secondary endpoints at 16 weeks, and updated data support the potential for once-yearly dosing ...
KT-621 is expected to start Phase 1 in October, with Phase 1 data in the first half of 2025 WATERTOWN, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (KYMR) (NASDAQ: KYMR), a ...
(RTTNews) - Elekta AB Ser. B (EKTA-B.ST) announced that the U.S. Food and Drug Administration has granted 510(k) clearance for its Leksell Gamma Knife radiosurgery system to treat refractory, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results